MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Richard Jude Samulski
Richard Jude SamulskiASKLEPIOS BIOPHARMACEUTICAL INC

Richard Jude Samulski

Chief Scientific Officer and Co-Founder at ASKLEPIOS BIOPHARMACEUTICAL INC

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 3.05 B
Avg. Deal Size£ 3.05 B

Market Context

Sort

26 Oct 2020|United States|Biotechnology
Asklepios Biopharmaceutical
Bayer

Target: ASKLEPIOS BIOPHARMACEUTICAL INC

Bidder: BAYER AG

10 Service Providers

4 Target | 3 Bidder | 3 Vendor

38 Dealmakers

20 Target | 8 Bidder | 10 Vendor

£ 3.05 B

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite